Website News and Research

RSS

HTDS Collagenna Skin Care Products enters into exclusive distribution agreement with Medimec

Hard to Treat Diseases Collagenna Skin care Products has entered into an exclusive distribution agreement with the Malaysian company Medimec www.medimec.com.my

21 May 2010

Data on retreatment experiences with brentuximab vedotin in clinical trials to be presented at 2010 ASCO

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that data regarding retreatment experiences with brentuximab vedotin in phase I and phase II clinical trials will be presented during a poster session at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8, 2010 in Chicago, Illinois.

21 May 2010

PTCL trial data on belinostat to be presented at 2010 ASCO Annual Meeting

Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in hematology and oncology, today announced that clinical data on belinostat will be presented at the 2010 Annual Meeting of the American Society of Clinical Oncology, to be held June 4-8, 2010 at the McCormick Place Convention Center in Chicago, Illinois, as part of the ASCO proceedings.

21 May 2010

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Oncolytics Biotech Inc. announced today that abstracts covering clinical research with reovirus (REOLYSIN(R)) are available on the American Society of Clinical Oncology website at www.asco.org, and on the Oncolytics website at www.oncolyticsbiotech.com.

21 May 2010

Psychiatrists should be included in disaster first-response teams

Psychiatrists should be included in disaster first-response teams because survivors have immediate need for help in alleviating early trauma symptoms ranging from sleeplessness to constant anxiety, says a new study of 9/11 survivors and victims' family members published today in the Journal of Psychiatric Practice.

21 May 2010

Nektar Therapeutics to present data of NKTR-102 Phase 2 clinical trial in ovarian cancer at 46th ASCO

Nektar Therapeutics today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).

21 May 2010

ZIOPHARM Oncology to present phase II data from PICASSO trial for soft tissue sarcoma at ASCO meeting

ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque, lead author of the abstract on the palifosfamide study entitled, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients with soft tissue sarcoma (PICASSO)", will present in an oral session at the American Society of Clinical Oncology (ASCO) Annual Meeting on Monday, June 7th at 2:15 pm in the Vista Room (location S 406).

21 May 2010

MSCRF awards grants to 42 projects under Maryland Stem Cell Research Act of 2006

The Maryland Stem Cell Research Commission has completed its evaluation of the 141 applications in response to its three official Requests for Applications during the FY 2010 funding cycle. The board of directors of the Maryland Technology Development Corporation reviewed the Commission's recommendations and approved 42 projects totaling $11.7 million in funding through the Maryland Stem Cell Research Fund under the Maryland Stem Cell Research Act of 2006.

21 May 2010

AORN develops new Comprehensive Surgical Checklist

The Association of periOperative Registered Nurses (AORN) has developed a comprehensive surgical checklist to help reduce the number of wrong-site surgeries and other preventable mistakes that occur in U.S. operating rooms. The new AORN Comprehensive Surgical Checklist includes the safety checks outlined in the World Health Organization (WHO) Surgical Safety Checklist, and also meets the safety checks included in The Joint Commission Universal Protocol that meet the accreditation requirements.

21 May 2010

Lawmakers probe consumer genetic testing kits

After Pathway Genomics proposed selling genetics tests directly to consumers without Food and Drug Administration approval and "despite concerns" about accuracy, lawmakers have launched an investigation and requested information about the products according to letters sent to three firms by a House panel, The Washington Post reports.

20 May 2010

GeoVax Labs spotlighted on interactive map posted on the website of Inc. magazine

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, is spotlighted on an interactive map posted on the website of Inc. magazine.

20 May 2010

Stockell Healthcare Systems launches new website

Stockell Healthcare Systems, Inc. is pleased to announce the unveiling of its new website at www.stockell.com.

20 May 2010

Elevated levels of Lp-PLA2 associated with increased risk of coronary heart disease

A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010. The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme, are associated with an increased risk of coronary heart disease similar in magnitude to that with non-HDL cholesterol or systolic blood pressure.

20 May 2010

realbuzz.com suggests tips to reinvigorate your regime

As the summer approaches do you make the most out of our time off? Do you maximise your lunch hour and time off after work? How do you revitalize yourself to make sure you feel on top of the World? Many of us forget about the small things that can instantly change the way you feel and only involve minimum impact and cost. realbuzz.com the healthy active living website suggests a few small ways to reinvigorate your regime.

20 May 2010

HTDS commences subscription to Pink Sheets news and filing service

Hard to Treat Diseases, Inc. announces that the company has commenced to subscribe to Pink Sheets news and filing service after a brief absence.

19 May 2010

HHS sends letter to Committee on Education and Labor over improper practices by Head Start grantees

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.

19 May 2010

Cincinnati Children's Hospital Medical Center launches REGID

A new nationwide registry will allow researchers to conduct larger, more effective studies of often misdiagnosed disorders that affect thousands of children in the United States.

19 May 2010

RegeneRx Biopharmaceuticals prices underwritten public offering at $0.41 per unit

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced the pricing of its previously announced underwritten public offering of 11,500,000 units of its securities at a public offering price of $0.41 per unit.

19 May 2010

Where are Australia’s missing hepatitis C cases?

Around 90% of those infected have not received treatment, despite the potential for cure, a report to coincide with National Hepatitis Week shows

18 May 2010

ICU-acquired infection rates are not indication of patients' mortality risk: Researchers

ICU-acquired infection rates are not an indication of patients' mortality risk, according to researchers the University of Pennsylvania, undermining a central tenet of many pay-for-performance initiatives.

18 May 2010

Website News and Research

HTDS Collagenna Skin Care Products enters into exclusive distribution agreement with Medimec

Data on retreatment experiences with brentuximab vedotin in clinical trials to be presented at 2010 ASCO

PTCL trial data on belinostat to be presented at 2010 ASCO Annual Meeting

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Psychiatrists should be included in disaster first-response teams

Nektar Therapeutics to present data of NKTR-102 Phase 2 clinical trial in ovarian cancer at 46th ASCO

ZIOPHARM Oncology to present phase II data from PICASSO trial for soft tissue sarcoma at ASCO meeting

MSCRF awards grants to 42 projects under Maryland Stem Cell Research Act of 2006

AORN develops new Comprehensive Surgical Checklist

Lawmakers probe consumer genetic testing kits

GeoVax Labs spotlighted on interactive map posted on the website of Inc. magazine

Stockell Healthcare Systems launches new website

Elevated levels of Lp-PLA2 associated with increased risk of coronary heart disease

realbuzz.com suggests tips to reinvigorate your regime

HTDS commences subscription to Pink Sheets news and filing service

HHS sends letter to Committee on Education and Labor over improper practices by Head Start grantees

Cincinnati Children's Hospital Medical Center launches REGID

RegeneRx Biopharmaceuticals prices underwritten public offering at $0.41 per unit

Where are Australia’s missing hepatitis C cases?

ICU-acquired infection rates are not indication of patients' mortality risk: Researchers

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News